MIR
Mirion Technologies, Inc.
Company overview
- Market capitalization
- —
- Employees
- 2,800
- Latest publication
- 2026-09-29
About Mirion Technologies, Inc.
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 257,600,000USD | 277,400,000USD | 223,100,000USD | 222,900,000USD | 202,000,000USD | 254,300,000USD | 206,800,000USD | 207,100,000USD |
| Cost Of Revenue | 138,500,000USD | 142,100,000USD | 118,600,000USD | 120,200,000USD | 105,900,000USD | 131,900,000USD | 112,400,000USD | 109,200,000USD |
| Gross Profit | 119,100,000USD | 135,300,000USD | 104,500,000USD | 102,700,000USD | 96,100,000USD | 122,400,000USD | 94,400,000USD | 97,900,000USD |
| Research Development | 9,600,000USD | 10,100,000USD | 10,100,000USD | 10,000,000USD | 8,700,000USD | 8,100,000USD | 10,200,000USD | 8,800,000USD |
| Selling General Administrative | 105,800,000USD | 99,900,000USD | 87,000,000USD | 8,088,000USD | 78,700,000USD | 83,300,000USD | 84,300,000USD | 87,500,000USD |
| Total Operating Expenses | 115,400,000USD | 110,000,000USD | 97,100,000USD | 92,800,000USD | 87,400,000USD | 93,400,000USD | 96,000,000USD | 95,600,000USD |
| Operating Income | 3,700,000USD | 25,500,000USD | 7,400,000USD | 9,900,000USD | 8,700,000USD | 29,000,000USD | -1,600,000USD | 2,300,000USD |
| Interest Income | 3,400,000USD | 2,500,000USD | 2,200,000USD | 3,700,000USD | 1,900,000USD | 1,500,000USD | 1,400,000USD | 2,000,000USD |
| Interest Expense | 8,400,000USD | 9,000,000USD | 8,900,000USD | 11,800,000USD | 12,500,000USD | 13,200,000USD | 14,100,000USD | 15,100,000USD |
| Net Interest Income | -5,000,000USD | -3,000,000USD | -6,700,000USD | -9,800,000USD | -10,600,000USD | -11,700,000USD | -12,700,000USD | -13,100,000USD |
| Income Before Tax | -5,200,000USD | 23,100,000USD | 1,200,000USD | 7,800,000USD | 600,000USD | 15,700,000USD | -13,000,000USD | -11,300,000USD |
| Income Tax Expense | -1,800,000USD | 5,300,000USD | -1,900,000USD | -700,000USD | 200,000USD | -200,000USD | 1,000,000USD | 700,000USD |
| Tax Provision | -1,800,000USD | 5,300,000USD | -1,900,000USD | -700,000USD | 200,000USD | -200,000USD | 1,000,000USD | 700,000USD |
| Net Income | -3,400,000USD | 17,300,000USD | 2,900,000USD | 8,300,000USD | 300,000USD | 15,000,000USD | -13,600,000USD | -11,700,000USD |
| Net Income From Continuing Ops | -3,400,000USD | 17,800,000USD | 3,100,000USD | 8,500,000USD | 400,000USD | 15,900,000USD | -14,000,000USD | -12,000,000USD |
| Ebit | 3,200,000USD | 32,100,000USD | 10,100,000USD | 10,300,000USD | 13,100,000USD | 29,300,000USD | 200,000USD | 4,000,000USD |
| Ebitda | 44,000,000USD | 67,800,000USD | 44,900,000USD | 44,100,000USD | 46,800,000USD | 63,900,000USD | 38,800,000USD | 42,400,000USD |
| Depreciation And Amortization | 40,800,000USD | 35,700,000USD | 34,800,000USD | 33,800,000USD | 33,700,000USD | 34,600,000USD | 38,600,000USD | 38,400,000USD |
| Reconciled Depreciation | 40,800,000USD | 35,600,000USD | 34,900,000USD | 33,800,000USD | 33,700,000USD | 34,600,000USD | 38,600,000USD | 38,400,000USD |
| Total Other Income Expense Net | -8,900,000USD | -2,399,999USD | -6,200,000USD | -2,100,000USD | -8,100,000USD | -13,300,000USD | -11,400,000USD | -13,600,000USD |
| Minority Interest | 0USD | -500,000USD | -200,000USD | -200,000USD | -100,000USD | -900,000USD | 400,000USD | 300,000USD |
| Net Income Applicable To Common Shares | — | 17,300,000USD | 2,900,000USD | 8,300,000USD | 300,000USD | 15,000,000USD | -13,600,000USD | — |
| Unclassified Operating Expenses | — | — | — | 74,712,000USD | — | — | 1,500,000USD | — |
| Selling And Marketing Expenses | — | — | — | — | — | 1,700,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20092009-12-31 · USD | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 925,400,000USD | 860,800,000USD | 611,600,000USD | 478,200,000USD | — | — | — | — |
| Cost Of Revenue | 486,800,000USD | 459,000,000USD | 359,800,000USD | 281,200,000USD | — | — | — | — |
| Gross Profit | 438,600,000USD | 401,800,000USD | 251,800,000USD | 197,000,000USD | — | — | — | — |
| Research Development | 38,900,000USD | 35,000,000USD | 29,400,000USD | 15,900,000USD | — | — | — | — |
| Selling General Administrative | 348,200,000USD | 336,500,000USD | 2,449USD | 2,449,094USD | — | — | — | — |
| Total Operating Expenses | 387,100,000USD | 377,000,000USD | 240,600,000USD | 2,449,094USD | — | — | — | — |
| Operating Income | 51,500,000USD | 24,800,000USD | 11,200,000USD | -2,449,094USD | — | — | — | — |
| Interest Income | 12,700,000USD | 6,600,000USD | 58,800,000USD | 176,600,000USD | — | — | — | — |
| Interest Expense | 42,200,000USD | 57,900,000USD | 41,000,000USD | 134,082USD | 0USD | 0USD | 0USD | 0USD |
| Net Interest Income | -30,100,000USD | -51,300,000USD | — | — | — | — | — | — |
| Income Before Tax | 32,700,000USD | -33,900,000USD | -164,300,000USD | -45,521,304USD | — | — | — | — |
| Income Tax Expense | 2,900,000USD | 2,700,000USD | -5,900,000USD | -265,897USD | 7,732,000USD | 5,612,000USD | 5,838,000USD | 4,937,000USD |
| Tax Provision | 2,900,000USD | 2,700,000USD | -12,400,000USD | -265,897USD | — | — | — | — |
| Net Income | 28,800,000USD | -36,100,000USD | -158,300,000USD | -45,255,407USD | — | — | — | — |
| Net Income From Continuing Ops | 29,800,000USD | -36,600,000USD | — | -1,041,135USD | — | — | — | — |
| Ebit | 74,900,000USD | 28,600,000USD | 11,200,000USD | -2,449,094USD | 28,178,000USD | 18,878,000USD | 10,937,000USD | 3,388,000USD |
| Ebitda | 212,900,000USD | 179,000,000USD | 11,237,000USD | 68,550,906USD | — | — | — | — |
| Depreciation And Amortization | 138,000,000USD | 150,400,000USD | 37,000USD | 71,000,000USD | — | — | — | — |
| Reconciled Depreciation | 138,000,000USD | 150,400,000USD | — | — | — | — | — | — |
| Total Other Income Expense Net | -18,799,999USD | -58,700,000USD | -175,500,000USD | -43,072,210USD | — | — | — | — |
| Minority Interest | -1,000,000USD | 500,000USD | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | 28,800,000USD | -36,100,000USD | -255,800,000USD | -158,300,000USD | -4,958,000USD | -13,847,000USD | -22,342,000USD | -27,842,000USD |
| Selling And Marketing Expenses | — | 1,700,000USD | 800,000USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | 3,800,000USD | 210,397,551USD | -15,900,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,535,900,000USD | 3,588,100,000USD | 3,495,800,000USD | 2,737,800,000USD | 2,625,600,000USD | 2,636,000,000USD | 2,653,900,000USD | 2,627,300,000USD |
| Intangible Assets | 576,000,000USD | 606,300,000USD | 381,500,000USD | 377,200,000USD | 390,700,000USD | 411,600,000USD | 447,300,000USD | 479,410,000USD |
| Other Current Assets | 33,100,000USD | 31,900,000USD | 31,600,000USD | 31,600,000USD | 28,100,000USD | 35,700,000USD | 33,100,000USD | 30,800,000USD |
| Total Liab | 1,647,400,000USD | 1,671,200,000USD | 1,603,800,000USD | 1,224,200,000USD | 1,068,900,000USD | 1,076,900,000USD | 1,079,000,000USD | 1,063,200,000USD |
| Total Stockholder Equity | 1,838,300,000USD | 1,866,400,000USD | 1,841,300,000USD | 1,462,300,000USD | 1,503,800,000USD | 1,505,600,000USD | 1,518,900,000USD | 1,507,800,000USD |
| Other Current Liab | 81,300,000USD | 117,600,000USD | 107,600,000USD | 98,600,000USD | 99,200,000USD | 70,500,000USD | 92,300,000USD | 58,400,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -516,100,000USD | -512,700,000USD | -530,000,000USD | -532,900,000USD | -541,200,000USD | -541,500,000USD | -556,500,000USD | -542,900,000USD |
| Good Will | 1,860,400,000USD | 1,872,400,000USD | 1,525,600,000USD | 1,470,700,000USD | 1,439,600,000USD | 1,426,200,000USD | 1,452,600,000USD | 1,436,400,000USD |
| Cash | 397,900,000USD | 412,300,000USD | 933,500,000USD | 262,600,000USD | 185,800,000USD | 175,200,000USD | 133,300,000USD | 122,200,000USD |
| Cash And Short Term Investments | 404,900,000USD | 419,200,000USD | 940,000,000USD | 268,700,000USD | 191,700,000USD | 181,100,000USD | 139,100,000USD | 127,800,000USD |
| Total Current Assets | 890,900,000USD | 893,700,000USD | 1,386,600,000USD | 693,200,000USD | 590,200,000USD | 594,700,000USD | 546,500,000USD | 515,400,000USD |
| Total Current Liabilities | 279,200,000USD | 316,100,000USD | 287,000,000USD | 272,400,000USD | 265,000,000USD | 263,500,000USD | 252,600,000USD | 236,200,000USD |
| Current Deferred Revenue | 122,500,000USD | 131,800,000USD | 107,900,000USD | 105,700,000USD | 106,900,000USD | 110,900,000USD | 88,800,000USD | 109,200,000USD |
| Net Debt | 836,000,000USD | 821,400,000USD | 299,300,000USD | 602,500,000USD | 533,700,000USD | 544,700,000USD | 587,000,000USD | 596,800,000USD |
| Short Term Debt | 9,300,000USD | 9,300,000USD | 8,800,000USD | 7,100,000USD | 7,200,000USD | 7,600,000USD | 7,300,000USD | 6,700,000USD |
| Short Long Term Debt | 1,600,000USD | 1,600,000USD | 1,600,000USD | 400,000USD | 700,000USD | 1,200,000USD | 600,000USD | 100,000USD |
| Short Long Term Debt Total | 1,233,900,000USD | 1,233,700,000USD | 1,232,800,000USD | 865,100,000USD | 719,500,000USD | 719,900,000USD | 720,300,000USD | 719,000,000USD |
| Long Term Debt | 1,199,100,000USD | 1,197,600,000USD | 1,196,800,000USD | 832,400,000USD | 685,900,000USD | 685,200,000USD | 684,500,000USD | 684,000,000USD |
| Short Term Investments | 7,000,000USD | 6,900,000USD | 6,500,000USD | 6,100,000USD | 5,900,000USD | 5,900,000USD | 5,800,000USD | 5,600,000USD |
| Net Receivables | 295,000,000USD | 290,000,000USD | 269,000,000USD | 247,800,000USD | 226,900,000USD | 244,700,000USD | 220,300,000USD | 208,500,000USD |
| Inventory | 157,900,000USD | 152,600,000USD | 146,000,000USD | 145,100,000USD | 143,500,000USD | 133,200,000USD | 154,000,000USD | 148,300,000USD |
| Accounts Payable | 66,100,000USD | 57,400,000USD | 49,400,000USD | 45,600,000USD | 51,700,000USD | 56,500,000USD | 53,100,000USD | 52,200,000USD |
| Property Plant Equipment Net | 183,400,000USD | 187,000,000USD | 185,400,000USD | 182,900,000USD | 178,200,000USD | 176,600,000USD | 178,400,000USD | 165,090,000USD |
| Property Plant Equipment Gross | 287,200,000USD | 283,400,000USD | 288,700,000USD | 280,200,000USD | 267,000,000USD | 257,800,000USD | 229,400,000USD | 229,900,000USD |
| Accumulated Other Comprehensive Income | -62,600,000USD | -52,600,000USD | -57,100,000USD | -56,300,000USD | -79,100,000USD | -93,000,000USD | -59,600,000USD | -79,500,000USD |
| Common Stock Shares Outstanding | 244,663,000shares | 261,154,000shares | 255,662,000shares | 243,594,000shares | 226,918,000shares | 204,991,000shares | 206,676,000shares | 202,197,000shares |
| Non Current Assets Total | 2,645,000,000USD | 2,694,400,000USD | 2,109,300,000USD | 2,044,600,000USD | 2,035,400,000USD | 2,041,300,000USD | 2,107,400,000USD | 2,111,800,000USD |
| Non Current Liabilities Total | 1,368,200,000USD | 1,355,100,000USD | 1,316,800,000USD | 951,800,000USD | 803,900,000USD | 813,500,000USD | 826,400,000USD | 827,000,000USD |
| Non Current Liabilities Other | 75,500,000USD | 60,700,000USD | 41,000,000USD | 40,200,000USD | 37,500,000USD | 40,000,000USD | 49,300,000USD | 44,500,000USD |
| Non Currrent Assets Other | 25,200,000USD | 28,700,000USD | 16,500,000USD | 13,800,000USD | 26,900,000USD | 26,900,000USD | 29,000,000USD | 30,900,000USD |
| Net Working Capital | 611,700,000USD | 577,600,000USD | 1,099,600,000USD | 420,800,000USD | 325,200,000USD | 331,200,000USD | 293,900,000USD | 279,200,000USD |
| Unclassified Non Current Liabilities | 93,600,000USD | 96,800,000USD | 79,000,000USD | 79,200,000USD | 80,500,000USD | 88,300,000USD | 92,600,000USD | 98,500,000USD |
| Unclassified Equity | 2,417,000,000USD | 2,431,674,960USD | 2,428,375,010USD | 2,051,476,610USD | 2,124,076,850USD | 2,140,076,760USD | 2,134,976,820USD | 2,130,200,000USD |
| Common Stock | — | 25,040USD | 24,990USD | 23,390USD | 23,150USD | 23,240USD | 23,180USD | — |
| Other Assets | — | 24,600,000USD | -100,000USD | 13,800,000USD | 7,100,000USD | 6,700,000USD | 29,000,000USD | 100,000USD |
| Cash And Equivalents | — | 412,300,000USD | 933,200,000USD | 262,600,000USD | 185,800,000USD | 175,200,000USD | 133,300,000USD | — |
| Unclassified Current Liabilities | — | — | 11,700,000USD | 15,000,000USD | — | 16,800,000USD | 10,500,000USD | 9,600,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | -28,900,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,588,100,000USD | 2,636,000,000USD | 2,718,500,000USD | 2,738,700,000USD | 3,118,000,000USD | 751,315,411USD | 5,000USD | 5,000USD |
| Intangible Assets | 606,300,000USD | 411,600,000USD | 538,800,000USD | 650,400,000USD | 806,900,000USD | 248,300,000USD | 270,500,000USD | — |
| Other Current Assets | 43,700,000USD | 35,700,000USD | 30,000,000USD | 33,900,000USD | 21,200,000USD | 599,170USD | 19,500,000USD | 4,400,000USD |
| Total Liab | 1,671,200,000USD | 1,076,900,000USD | 1,168,500,000USD | 1,271,500,000USD | 1,334,000,000USD | 27,590,427USD | 636USD | 295USD |
| Total Stockholder Equity | 1,866,400,000USD | 1,505,600,000USD | 1,484,500,000USD | 1,398,200,000USD | 1,693,200,000USD | 723,724,984USD | 4,364USD | 4,705USD |
| Other Current Liab | 137,100,000USD | 70,500,000USD | 91,300,000USD | 65,600,000USD | 55,900,000USD | 375,057USD | 636USD | 50,500,000USD |
| Common Stock | 25,040USD | 23,240USD | 22,600USD | 20,800USD | 100,000USD | 718,727,169USD | 2,012USD | 2,012USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 718,727,169USD | 2,012USD | 2,012USD |
| Retained Earnings | -512,700,000USD | -541,500,000USD | -505,400,000USD | -408,500,000USD | -131,600,000USD | -1,041,771USD | -636USD | -295USD |
| Good Will | 1,872,400,000USD | 1,426,200,000USD | 1,447,600,000USD | 1,418,000,000USD | 1,662,600,000USD | 522,600,000USD | 511,600,000USD | — |
| Other Assets | 24,600,000USD | 6,700,000USD | 26,100,000USD | 24,800,000USD | 24,500,000USD | 16,700,000USD | -845,000,000USD | 10,400,000USD |
| Cash | 415,100,000USD | 175,200,000USD | 128,800,000USD | 73,500,000USD | 84,000,000USD | 383,246USD | 5,000USD | 5,000USD |
| Cash And Equivalents | 412,300,000USD | 175,200,000USD | 128,800,000USD | 73,500,000USD | 84,000,000USD | 101,100,000USD | 118,400,000USD | — |
| Cash And Short Term Investments | 422,000,000USD | 181,100,000USD | 134,100,000USD | 77,800,000USD | 88,900,000USD | 383,246USD | 5,000USD | 5,000USD |
| Total Current Assets | 897,800,000USD | 594,700,000USD | 538,600,000USD | 480,600,000USD | 453,400,000USD | 982,416USD | 5,000USD | 5,000USD |
| Total Current Liabilities | 316,100,000USD | 263,500,000USD | 265,700,000USD | 244,300,000USD | 221,000,000USD | 1,340,427USD | 636USD | 295USD |
| Current Deferred Revenue | 112,300,000USD | 110,900,000USD | 103,400,000USD | 83,000,000USD | 81,800,000USD | -41,100,000USD | -10,500,636USD | — |
| Net Debt | 818,600,000USD | 544,700,000USD | 592,200,000USD | 776,100,000USD | 776,600,000USD | 1,697,616,754USD | 1,475,295,000USD | -5,000USD |
| Short Term Debt | 9,300,000USD | 7,600,000USD | 8,100,000USD | 13,800,000USD | 13,200,000USD | 41,100,000USD | 10,500,000USD | — |
| Short Long Term Debt | 1,600,000USD | 1,200,000USD | 1,200,000USD | 5,300,000USD | 3,900,000USD | — | — | — |
| Short Long Term Debt Total | 1,233,700,000USD | 719,900,000USD | 721,000,000USD | 849,600,000USD | 860,600,000USD | 2,097,300,000USD | 1,667,400,000USD | — |
| Long Term Debt | 1,197,600,000USD | 685,200,000USD | 684,700,000USD | 801,500,000USD | 806,800,000USD | 2,056,200,000USD | 1,656,900,000USD | — |
| Short Term Investments | 6,900,000USD | 5,900,000USD | 5,300,000USD | 4,300,000USD | 4,900,000USD | — | — | — |
| Net Receivables | 280,200,000USD | 244,700,000USD | 230,400,000USD | 225,600,000USD | 219,700,000USD | 156,800,000USD | 156,000,000USD | 156,000,000USD |
| Inventory | 151,900,000USD | 133,200,000USD | 144,100,000USD | 143,300,000USD | 123,600,000USD | 90,200,000USD | 89,300,000USD | 89,300,000USD |
| Accounts Payable | 57,400,000USD | 56,500,000USD | 58,700,000USD | 67,700,000USD | 59,400,000USD | 965,370USD | 636USD | 295USD |
| Property Plant Equipment Net | 187,000,000USD | 176,600,000USD | 167,400,000USD | 164,900,000USD | 169,700,000USD | 75,200,000USD | 62,900,000USD | 62,900,000USD |
| Property Plant Equipment Gross | 283,400,000USD | 257,800,000USD | 223,900,000USD | 164,400,000USD | 169,700,000USD | — | — | — |
| Accumulated Other Comprehensive Income | -52,600,000USD | -93,000,000USD | -65,300,000USD | -75,700,000USD | -20,700,000USD | -750,000,000USD | 10,900,000USD | — |
| Common Stock Shares Outstanding | 261,154,000shares | 204,991,000shares | 196,369,000shares | 181,149,109shares | 208,083,832shares | 56,994,863shares | 20,125,000shares | 95,125,000shares |
| Non Current Assets Total | 2,690,300,000USD | 2,041,300,000USD | 2,179,900,000USD | 2,233,300,000USD | 2,664,600,000USD | 750,332,995USD | 845,000,000USD | 0USD |
| Non Current Liabilities Total | 1,355,100,000USD | 813,500,000USD | 902,800,000USD | 1,027,200,000USD | 1,113,000,000USD | 26,250,000USD | 1,464,800,000USD | 295USD |
| Non Current Liabilities Other | 60,700,000USD | 40,000,000USD | 50,700,000USD | 44,600,000USD | 36,500,000USD | — | — | — |
| Non Currrent Assets Other | 24,600,000USD | 26,900,000USD | 26,100,000USD | -116,300,000USD | 25,400,000USD | -846,100,000USD | -845,000,000USD | — |
| Net Working Capital | 577,600,000USD | 331,200,000USD | 272,900,000USD | 236,300,000USD | 232,500,000USD | -358,011USD | 4,364USD | 4,705USD |
| Unclassified Non Current Liabilities | 96,800,000USD | 88,300,000USD | 167,400,000USD | — | — | -2,172,250,000USD | -312,000,000USD | -135,599,705USD |
| Unclassified Equity | 2,431,674,960USD | 2,140,076,760USD | 2,055,177,400USD | 1,882,379,200USD | 1,845,400,000USD | 37,312,417USD | -10,899,024USD | — |
| Unclassified Current Liabilities | — | 16,800,000USD | 3,000,000USD | 8,900,000USD | 6,800,000USD | -41,100,000USD | -10,500,636USD | -50,500,000USD |
| Unclassified Non Current Assets | — | — | -26,100,000USD | -24,800,000USD | — | -112,467,005USD | — | -73,300,000USD |
| Other Liab | — | — | — | 191,300,000USD | 265,600,000USD | 142,300,000USD | 119,900,000USD | 135,600,000USD |
| Net Tangible Assets | — | — | — | -670,200,000USD | -776,300,000USD | -1,849,400,000USD | -1,489,600,000USD | -1,372,400,000USD |
| Unclassified Current Assets | — | — | — | — | — | -247,000,000USD | -264,800,000USD | -249,700,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,400,000USD | 17,300,000USD | 3,100,000USD | 8,300,000USD | 300,000USD | 15,900,000USD | -14,000,000USD | -12,000,000USD |
| Depreciation | 40,800,000USD | 35,600,000USD | 34,900,000USD | 33,800,000USD | 33,700,000USD | 34,600,000USD | 38,600,000USD | 38,400,000USD |
| Stock Based Compensation | 4,300,000USD | 4,000,000USD | 4,500,000USD | 6,700,000USD | 3,400,000USD | 3,700,000USD | 4,300,000USD | 4,000,000USD |
| Other Non Cash Items | 7,000,000USD | 9,600,000USD | 2,200,000USD | -3,700,000USD | 200,000USD | 6,100,000USD | 2,300,000USD | 2,400,000USD |
| Change To Account Receivables | -6,500,000USD | -16,800,000USD | -22,000,000USD | 8,100,000USD | 29,000,000USD | -32,600,000USD | -9,500,000USD | -9,800,000USD |
| Change To Inventory | -6,500,000USD | 9,600,000USD | -1,800,000USD | 3,800,000USD | -8,300,000USD | 13,400,000USD | -3,600,000USD | -2,900,000USD |
| Change In Working Capital | -27,200,000USD | 26,400,000USD | -20,100,000USD | -26,400,000USD | 4,400,000USD | 4,400,000USD | -8,600,000USD | -10,700,000USD |
| Total Cash From Operating Activities | 18,900,000USD | 76,100,000USD | 22,300,000USD | 9,800,000USD | 35,600,000USD | 60,800,000USD | 17,100,000USD | 15,200,000USD |
| Capital Expenditures | -9,500,000USD | -9,800,000USD | -9,300,000USD | -8,800,000USD | -8,500,000USD | -11,700,000USD | -13,200,000USD | -11,100,000USD |
| Free Cash Flow | 9,400,000USD | 66,300,000USD | 13,000,000USD | 1,000,000USD | 27,100,000USD | 49,100,000USD | 3,900,000USD | 4,100,000USD |
| Investments | 300,000USD | 300,000USD | -88,100,000USD | -8,100,000USD | -7,600,000USD | -9,600,000USD | -12,300,000USD | -8,900,000USD |
| Total Cashflows From Investing Activities | -9,200,000USD | -590,800,000USD | -88,100,000USD | -8,100,000USD | -7,600,000USD | -9,600,000USD | -12,300,000USD | -8,900,000USD |
| Total Cash From Financing Activities | -19,900,000USD | -5,900,000USD | 737,500,000USD | 65,000,000USD | -21,200,000USD | -1,300,000USD | 800,000USD | -3,000,000USD |
| Sale Purchase Of Stock | -16,000,000USD | 5,200,000USD | 5,200,000USD | -34,300,000USD | -20,500,000USD | -1,000,000USD | -1,000,000USD | -1,000,000USD |
| Change In Cash | -14,400,000USD | -521,200,000USD | 670,600,000USD | 76,799,999USD | 10,600,000USD | 41,900,000USD | 9,900,000USD | 2,100,000USD |
| Begin Period Cash Flow | 415,200,000USD | 933,500,000USD | 263,000,000USD | 186,100,000USD | 175,600,000USD | 133,700,000USD | 123,800,000USD | 121,700,000USD |
| End Period Cash Flow | 400,800,000USD | 412,300,000USD | 933,600,000USD | 262,899,999USD | 186,200,000USD | 175,600,000USD | 133,700,000USD | 123,800,000USD |
| Other Cashflows From Investing Activities | 300,000USD | 300,000USD | 1,100,000USD | 700,000USD | 900,000USD | 2,100,000USD | 4,000,000USD | 1,000,000USD |
| Other Cashflows From Financing Activities | -3,900,000USD | -6,400,000USD | -6,300,000USD | -2,600,000USD | -700,000USD | -300,000USD | 800,000USD | -2,000,000USD |
| Unclassified Operating Cash Flow | -2,600,000USD | -16,800,000USD | -2,300,000USD | -8,900,000USD | -6,400,000USD | -3,900,000USD | -5,500,000USD | -6,900,000USD |
| Net Borrowings | — | 0USD | 366,500,000USD | — | — | 0USD | 0USD | — |
| Issuance Of Capital Stock | — | 0USD | — | — | — | 0USD | 0USD | 0USD |
| Unclassified Investing Cash Flow | — | -581,600,000USD | 8,200,000USD | 8,100,000USD | 7,600,000USD | 9,600,000USD | 9,200,000USD | 10,100,000USD |
| Unclassified Financing Cash Flow | — | -4,700,000USD | 372,100,000USD | 101,900,000USD | — | — | 1,003,883USD | — |
| Dividends Paid | — | — | — | — | — | — | -3,883USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20092009-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 28,800,000USD | -36,600,000USD | -96,900,000USD | -288,400,000USD | -341USD | -103,700,000USD | -103,700,000USD | 5,965,000USD |
| Depreciation | 138,000,000USD | 150,400,000USD | 162,500,000USD | 174,500,000USD | 69,500,000USD | 77,000,000USD | 77,000,000USD | 12,052,000USD |
| Stock Based Compensation | 15,200,000USD | 15,600,000USD | 21,900,000USD | 31,800,000USD | 100,000USD | 200,000USD | 200,000USD | — |
| Other Non Cash Items | -700,000USD | 20,300,000USD | 39,300,000USD | 197,100,000USD | 67,200,000USD | 58,700,000USD | 58,700,000USD | — |
| Change To Account Receivables | 6,200,000USD | -12,000,000USD | -5,000,000USD | -19,300,000USD | 2,500,000USD | -11,300,000USD | -11,300,000USD | -7,276,000USD |
| Change To Inventory | 4,000,000USD | 1,300,000USD | -500,000USD | -34,800,000USD | -7,900,000USD | -6,000,000USD | -6,000,000USD | 484,000USD |
| Change In Working Capital | -15,700,000USD | -26,800,000USD | -700,000USD | -38,400,000USD | 341USD | -16,600,000USD | -16,600,000USD | -16,811,000USD |
| Total Cash From Operating Activities | 143,300,000USD | 99,100,000USD | 95,200,000USD | 39,400,000USD | 14,700,000USD | 15,600,000USD | 15,600,000USD | 8,202,000USD |
| Capital Expenditures | -36,400,000USD | -48,800,000USD | -37,100,000USD | -34,200,000USD | -16,500,000USD | -12,600,000USD | -12,600,000USD | -10,437,000USD |
| Free Cash Flow | 106,900,000USD | 50,300,000USD | 58,100,000USD | 5,200,000USD | -1,800,000USD | 3,000,000USD | 3,000,000USD | — |
| Investments | 2,700,000USD | -43,700,000USD | -64,700,000USD | -39,500,000USD | — | — | — | — |
| Total Cashflows From Investing Activities | -694,600,000USD | -43,700,000USD | -64,700,000USD | -39,500,000USD | -25,600,000USD | -12,600,000USD | -12,600,000USD | -11,174,000USD |
| Net Borrowings | 510,400,000USD | 0USD | -127,300,000USD | -6,600,000USD | 120,400,000USD | 23,600,000USD | -4,900,000USD | 8,140,000USD |
| Total Cash From Financing Activities | 775,900,000USD | -3,300,000USD | 22,600,000USD | -7,000,000USD | 15,000,000USD | -5,500,000USD | -5,500,000USD | 8,140,000USD |
| Sale Purchase Of Stock | -49,600,000USD | -2,000,000USD | -1,000,000USD | 0USD | — | — | — | — |
| Issuance Of Capital Stock | 425,000,000USD | 0USD | 150,000,000USD | 150,000,000USD | 750,000,000USD | — | — | — |
| Change In Cash | 239,600,000USD | 45,100,000USD | 55,500,000USD | -10,300,000USD | 82,400,000USD | -2,100,000USD | -2,100,000USD | 4,546,000USD |
| Begin Period Cash Flow | 175,600,000USD | 130,500,000USD | 75,000,000USD | 85,300,000USD | 5,000USD | 38,000,000USD | 38,000,000USD | — |
| End Period Cash Flow | 415,200,000USD | 175,600,000USD | 130,500,000USD | 75,000,000USD | 5,000USD | 35,900,000USD | 35,900,000USD | 5,000USD |
| Other Cashflows From Investing Activities | 3,700,000USD | 2,500,000USD | 2,800,000USD | 800,000USD | -9,100,000USD | -9,100,000USD | — | -737,000USD |
| Other Cashflows From Financing Activities | -6,800,000USD | -1,300,000USD | 900,000USD | -400,000USD | -8,600,000USD | -600,000USD | -600,000USD | — |
| Unclassified Operating Cash Flow | -22,300,000USD | -23,800,000USD | -30,900,000USD | -37,200,000USD | -122,100,000USD | — | — | 6,996,000USD |
| Unclassified Investing Cash Flow | -664,600,000USD | 46,300,000USD | 34,300,000USD | 33,400,000USD | — | 9,100,000USD | — | — |
| Unclassified Financing Cash Flow | 321,900,000USD | — | 150,000,000USD | — | -846,800,000USD | -28,500,000USD | — | — |
| Change To Liabilities | — | — | — | 11,400,000USD | -4,200,000USD | -11,100,000USD | 9,000,000USD | -10,019,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 4,700,000 | USD | 0001628280-26-028363 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 77,900,000 | USD | 0001628280-26-028363 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 175,000,000 | USD | 0001628280-26-028363 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 197,000,000 | USD | 0001628280-26-028363 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 60,600,000 | USD | 0001628280-26-028363 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Medical | 72,100,000 | USD | 0001628280-26-028363 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Nuclear Safety | 185,500,000 | USD | 0001628280-26-028363 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Asia Pacific | 4,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Europe | 104,600,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | North America | 168,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 212,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Services | 65,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Medical | 82,500,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Nuclear Safety | 194,900,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 15,600,000 | USD | 0001628280-26-009869 |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 327,600,000 | USD | 0001628280-26-009869 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 582,200,000 | USD | 0001628280-26-009869 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 690,600,000 | USD | 0001628280-26-009869 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 234,800,000 | USD | 0001628280-26-009869 |
| FY 2025Yearly · 2025-12-31 | Segment | Medical | 310,800,000 | USD | 0001628280-26-009869 |
| FY 2025Yearly · 2025-12-31 | Segment | Nuclear Safety | 614,600,000 | USD | 0001628280-26-009869 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia Pacific | 3,200,000 | USD | 0001628280-25-047169 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 75,700,000 | USD | 0001628280-25-047169 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 144,200,000 | USD | 0001628280-25-047169 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 166,100,000 | USD | 0001628280-25-047169 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 57,000,000 | USD | 0001628280-25-047169 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Medical | 78,500,000 | USD | 0001628280-25-047169 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Nuclear Safety | 144,600,000 | USD | 0001628280-25-047169 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia Pacific | 2,200,000 | USD | 0001809987-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 81,800,000 | USD | 0001809987-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Geography | North America | 138,900,000 | USD | 0001809987-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 164,200,000 | USD | 0001809987-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 58,700,000 | USD | 0001809987-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Medical | 81,200,000 | USD | 0001809987-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Nuclear Safety | 141,700,000 | USD | 0001809987-25-000011 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 5,800,000 | USD | 0001628280-26-028363 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 65,500,000 | USD | 0001628280-26-028363 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 130,700,000 | USD | 0001628280-26-028363 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 147,900,000 | USD | 0001628280-26-028363 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 54,100,000 | USD | 0001628280-26-028363 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Medical | 68,600,000 | USD | 0001628280-26-028363 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Nuclear Safety | 133,400,000 | USD | 0001628280-26-028363 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Asia Pacific | 3,100,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Europe | 95,400,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | North America | 155,800,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 195,800,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 58,500,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Medical | 85,600,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Nuclear Safety | 168,700,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 13,000,000 | USD | 0001628280-26-009869 |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 305,600,000 | USD | 0001628280-26-009869 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 542,200,000 | USD | 0001628280-26-009869 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 643,100,000 | USD | 0001628280-26-009869 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 217,700,000 | USD | 0001628280-26-009869 |
| FY 2024Yearly · 2024-12-31 | Segment | Medical | 299,700,000 | USD | 0001628280-26-009869 |
| FY 2024Yearly · 2024-12-31 | Segment | Nuclear Safety | 561,100,000 | USD | 0001628280-26-009869 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia Pacific | 2,900,000 | USD | 0001628280-25-047169 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 65,300,000 | USD | 0001628280-25-047169 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 138,600,000 | USD | 0001628280-25-047169 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 153,200,000 | USD | 0001628280-25-047169 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | 53,600,000 | USD | 0001628280-25-047169 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Medical | 74,100,000 | USD | 0001628280-25-047169 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Nuclear Safety | 132,700,000 | USD | 0001628280-25-047169 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Asia Pacific | 1,200,000 | USD | 0001809987-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Europe | 77,100,000 | USD | 0001809987-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Geography | North America | 128,800,000 | USD | 0001809987-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 154,100,000 | USD | 0001809987-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Product | Services | 53,000,000 | USD | 0001809987-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Medical | 73,200,000 | USD | 0001809987-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Nuclear Safety | 133,900,000 | USD | 0001809987-25-000011 |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 16,500,000 | USD | 0001628280-26-009869 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 272,100,000 | USD | 0001628280-26-009869 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 512,300,000 | USD | 0001628280-26-009869 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 597,800,000 | USD | 0001628280-26-009869 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 203,100,000 | USD | 0001628280-26-009869 |
| FY 2023Yearly · 2023-12-31 | Segment | Medical | 284,500,000 | USD | 0001628280-26-009869 |
| FY 2023Yearly · 2023-12-31 | Segment | Nuclear Safety | 516,400,000 | USD | 0001628280-26-009869 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 13,300,000 | USD | 0001628280-25-008233 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 241,800,000 | USD | 0001628280-25-008233 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 462,700,000 | USD | 0001628280-25-008233 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 533,000,000 | USD | 0001628280-25-008233 |
| FY 2022Yearly · 2022-12-31 | Product | Services | 184,800,000 | USD | 0001628280-25-008233 |
| FY 2022Yearly · 2022-12-31 | Segment | Medical | 271,700,000 | USD | 0001628280-25-008233 |
| FY 2022Yearly · 2022-12-31 | Segment | Nuclear Safety | 446,100,000 | USD | 0001628280-25-008233 |
| FY 2021Yearly · 2021-06-30 | Geography | Asia Pacific | 15,000,000 | USD | 0001628280-24-007670 |
| FY 2021Yearly · 2021-06-30 | Geography | Europe | 258,600,000 | USD | 0001628280-24-007670 |
| FY 2021Yearly · 2021-06-30 | Geography | North America | 338,000,000 | USD | 0001628280-24-007670 |
| FY 2021Yearly · 2021-06-30 | Product | Product | 459,300,000 | USD | 0001628280-24-007670 |
| FY 2021Yearly · 2021-06-30 | Product | Services | 152,300,000 | USD | 0001628280-24-007670 |
| FY 2021Yearly · 2021-06-30 | Segment | Medical | 155,700,000 | USD | 0001628280-24-007670 |
| FY 2021Yearly · 2021-06-30 | Segment | Technologies | 455,900,000 | USD | 0001628280-24-007670 |
| FY 2020Yearly · 2020-06-30 | Geography | Asia Pacific | 16,000,000 | USD | 0001628280-23-005646 |
| FY 2020Yearly · 2020-06-30 | Geography | Europe | 211,400,000 | USD | 0001628280-23-005646 |
| FY 2020Yearly · 2020-06-30 | Geography | North America | 250,800,000 | USD | 0001628280-23-005646 |
| FY 2020Yearly · 2020-06-30 | Product | Product | 353,000,000 | USD | 0001628280-23-005646 |
| FY 2020Yearly · 2020-06-30 | Product | Services | 125,200,000 | USD | 0001628280-23-005646 |
| FY 2020Yearly · 2020-06-30 | Segment | Industrial | 415,600,000 | USD | 0001628280-23-005646 |
| FY 2020Yearly · 2020-06-30 | Segment | Medical | 62,600,000 | USD | 0001628280-23-005646 |
| FY 2019Yearly · 2019-06-30 | Geography | Asia Pacific | 14,000,000 | USD | 0001628280-22-004286 |
| FY 2019Yearly · 2019-06-30 | Geography | Europe | 196,800,000 | USD | 0001628280-22-004286 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.